Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Nov-2017IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancerPalmieri, C; Szydlo, R; Miller, M; Barker, L; Patel, NH, et al
18-Sep-2017Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.Saleem, A; Searle, GE; Kenny, LM; Huiban, M; Kozlowski, K, et al
8-Sep-2017Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.Saleem, A; Searle, GE; Kenny, LM; Huiban, M; Kozlowski, K, et al
27-Jul-2016Stratified, precision or personalised medicine? Cancer services in the “real world” of a London hospitalDay, S; Coombes, RC; McGrath-Lone, L; Schoenborn, C; Ward, H, et al
14-Jun-2016CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancerPatel, H; Abduljabbar, R; Lai, CF; Periyasamy, M; Harrod, A, et al
14-Jun-2016Expression of CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor positive breast cancerPatel, H; Abduljabbar, R; Chun-Fui, L; Periyasamy, M; Harrod, A, et al
16-Aug-2017p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cellsPeriyasamy, M; Singh, A; Gemma, C; Kranjec, C; Farzan, R, et al